CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL Sébastien Perreault , Dong-Anh Khuong-Quang , Lindsay B Kilburn , Daniel B Landi , Sarah E S Leary , Simon Bailey , Valérie Larouche , Karsten Nysom , Pablo Hernáiz Driever , Patricia A Baxter , Olaf Witt , Michal Yalon Oren , Mohamed S Abdelbaki , Cassie Kline , Nicholas S Whipple , David S Ziegler , Jasper van der Lugt , Timothy E Hassall , Nicolas U Gerber , Devorah Segal , Jordan R Hansford , Geoffrey McCowage , Hyoung Jin Kang , Jung Woo Han , Darren Hargrave , Andrea T Franson , Helen Toledano , Nada Jabado , Nicholas G Gottardo , Susan N Chi , Liat Oren , Enrica E K Tan , Sabine Mueller , Molly E Hoke , Yeonhee Kim , Ashley Walter , Daniel Da Costa , Peter Manley , Angela J Waanders Neuro-Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
